Where the smart money is going: 5 insights on the state of healthcare investment in 2025
At the beginning of each year, we like to do a deep dive into the healthcare investment landscape. We do a retrospective on the previous year's activity, comb through all of the commentary from investor conferences , and pull data from the financial services firms. From all of these signals, we distill down to a smaller number of insights.
At a glance
Read on to get our full commentary, or use the links below to jump to a specific area of interest:
-
Insight #1: The provider space is experiencing ebbs and flows…
-
Insight #2: Drugmakers are betting big on chronic disease treatment…
-
Insight #3: The weight loss market remains a hot commodity,…
-
Insight #4: AI continues to buck the trend in the…
-
Insight #5: The new administration may be less friendly to…
At the beginning of each year, we like to do a deep dive into the healthcare investment landscape. We do a retrospective on the previous year’s activity, comb through all of the commentary from early-year conferences such as J.P. Morgan’s annual healthcare conference, and pull data from the various financial services firms that track year-over-year trends in investment. From all of these signals, we distill down to a smaller number of insights that we believe are revealing about the future trajectory of the industry in some way. In today’s post, we’ll share what we’re taking away about healthcare investment in 2025.
Insight #1: The provider space is experiencing ebbs and flows in dealmaking activity—reflecting this sector’s increasingly uneven financial performance.

Union Healthcare Insight
Log in to continue reading
Not a member yet? Create a free account for limited access.
Related insights
The new patient financial reality
The Great Utilization Shift
How one health system is creatively pushing back against a labor squeeze